Oncolytic Virotherapy for Drug-Resistant Multiple Myeloma

Project: Research project

Project Details

Description

Oncolytic Virotherapy for Drug-Resistant Multiple Myeloma Oncolytic Virotherapy for Drug-Resistant Multiple Myeloma Oncolytic Virotherapy with Myxoma Virus for Refractory Multiple Myeloma
StatusFinished
Effective start/end date9/1/178/31/19

Funding

  • HHS-NIH: National Cancer Institute (NCI): $179,080.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.